RecruitingACTRN12618001959268

BRAIN: Development of a detailed database for collection of clinical data in patients with brain cancer

BRAIN: Development of a detailed database for collection of clinical data in patients with brain cancer.


Sponsor

The Walter and Eliza Hall Institute of Medical Research

Enrollment

10,000 participants

Start Date

Feb 18, 2021

Study Type

Observational

Conditions

Summary

The aim of this study is to establish a comprehensive clinical registry for patients with brain tumours in Australia. Who is it for? You may be eligible to join this study if you are aged 18 years or above and have been diagnosed with a brain tumour. Study details Participants in this study will continue to receive routine clinical care, which will not be impacted by involvement in this study. All enrolled patients will have clinical data collected for up to 5 years. Data captured will include presentation and the disease course of brain tumours, surgical interventions, prescription of system therapies, and information regarding multi-disciplinary management and outcomes of this disease in the routine clinical practice setting. This registry will help to describe the current practice patterns and identify any deficiencies or abnormalities. By doing so, we can ensure that Australian brain tumour patients receive the best care possible.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Inclusion Criteria2

  • Histologically confirmed brain tumours including but not limited to glioma, meningioma, brain metastases and rare tumours including medulloblastoma and ependymoma.
  • Adults aged 18 years and above.

Exclusion Criteria1

  • Patients with cerebral lymphoma will be excluded.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

The follow-up period is 5 years. No additional tests are required, all data will be collected from the medical record of patients with histologically confirmed brain tumours. Data captured will includ

The follow-up period is 5 years. No additional tests are required, all data will be collected from the medical record of patients with histologically confirmed brain tumours. Data captured will include presentation and disease characteristics, surgical interventions, prescription of system therapies, and information regarding multi-disciplinary management and outcomes of this disease in the routine clinical practice setting.


Locations(13)

Royal Melbourne Hospital - City campus - Parkville

VIC, Australia

Peter MacCallum Cancer Centre - Melbourne

VIC, Australia

St Vincent's Hospital (Melbourne) Ltd - Fitzroy

VIC, Australia

St Vincent's Private Hospital - Fitzroy

VIC, Australia

Southwest Health Care - Warrnambool - Warrnambool

VIC, Australia

Royal Hobart Hospital - Hobart

VIC, Australia

Barwon Health - Geelong Hospital campus - Geelong

VIC, Australia

Bendigo Health Care Group - Bendigo Hospital - Bendigo

VIC, Australia

Austin Health - Austin Hospital - Heidelberg

VIC, Australia

The Alfred - Melbourne

VIC, Australia

Cabrini Hospital - Malvern - Malvern

VIC, Australia

Monash Medical Centre - Clayton campus - Clayton

VIC, Australia

Epworth Richmond - Richmond

VIC, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12618001959268


Related Trials